About The Course
Unlock the potential of MAOIs and TCAs by enhancing your understanding and application of MAOI antidepressants in modern psychiatric practice. This course explores the appropriate use and management of MAOIs and TCAs and guides you in identifying suitable patients for these medications. Learn the different types of MAOI and when to use them in managing depression, and recognize the absolute and relative contraindications for these medications.
Who Is This Course For?
This course is suitable for:
- Psychiatrists
- General Practitioners (GPs)
- Mental Health Nurse Practitioners (MHNPs)
- Psychologists
- Mental health professionals
- Clinicians working in or expanding into psychiatry and mental health care
Accreditation Information:
- Psychiatry Accreditation: This course is available for self-accreditation with the RANZCP and other relevant psychiatric and mental health organisations.
- GP Accreditation: This course is available for self-accreditation with RACGP for general practitioners.
What You'll Learn
- Develop an understanding of the clinical application of MAOIs and TCAs in modern psychiatry practice.
- Identify patients who are good candidates for TCAs and gaining insights into when to introduce these medications
- Compare the mechanism of action of MAOIs to SSRI, SNRI and TCAs
- Gain knowledge of the different types of MAOIs and when to use them in the management of depression
- Recognise absolute and relative contraindications for the use of MAOIs and TCAs
- Learn effective strategies for initiating treatment with MAOIs and managing their side effects
- Understand the augmentation options available for patients taking MAOIs
Course Programme
1 Unit | 1.5 hours total length
- Video: Mastering the Classics With Dr Gillman - Unlocking the Potential of MAOIs and TCAs in Modern Psychiatry
Course Description
Unlocking the Potential of MAOI Antidepressants and TCA Antidepressants in Modern Psychiatry
This course is designed to broaden your understanding of MAOIs and TCAs in modern psychiatry practice. This comprehensive program will enhance your clinical application of vital therapeutic alternatives within the realm of Major Depressive Disorder management.
While newer antidepressant medications may have gained popularity over the years, TCA antidepressants and MAOI antidepressants remain vital to psychiatric care. Members will explore topics such as the MAOI mechanism of action, the types of MAOIs, and a MAOI drug list. Participants will explore how MAOIs work compared to other medications, and absolute and relative contraindications for their use.
Other key topics include identifying patients suitable for TCAs, tricyclic antidepressants’ mechanism of action, and when to initiate TCA and MAOI treatment. SSRI, SNRI, TCA and MAOI distinctive features will be discussed, as well as an analysis of MAOIs vs. SSRIs and other antidepressants.
We will also cover effective management of side effects of MAOI antidepressants and TCA antidepressants ,and augmentation options for patients taking MAOIs. This will round out your educational experience and enable you in harnessing the full potential of these medications in your practice.
This course is an indispensable resource for any mental health professional seeking to enhance their expertise in the use of MAOI antidepressants and TCAs in treating depression. Participants will receive a completion certificate and 1.5 CPD hours upon completing the course.
While our Academy members enjoy exclusive access to a range of courses and webinars (including this course) with their annual membership, we’re pleased to offer you the opportunity to purchase it individually! Click here – Mastering the Classics With Dr Gillman: Unlocking the Potential of MAOIs and TCAs in Modern Psychiatry.
Enhance your knowledge and application of MAOIs and TCAs. Explore the appropriate use, management, side effects, and contraindications of MAOI antidepressants.
Course Information
- 1.5 hours
- 1.5 CPD
Inclusions
- 1.5 Hours of Video
- Certificate of Completion
Material Downloads
- certificate
Instructors
Dr. Ken Gillman Speaker | Chairman of International MAOI Expert Group
Dr. Ken Gillman is a world-renowned researcher and authority in the field of psychiatry, with a focus on serotonin toxicity, monoamine oxidase inhibitor (MAOI) antidepressant drugs, and related topics. He is currently the Principal Investigator and Director at PsychoTropical Research, where he leads a team of experts who publish papers in his areas of specialization in the peer-reviewed scientific literature.
Dr. Gillman’s research contributions have earned him an impressive H-index of 29 and a cumulative total of more than 4,500 citations. He has authored approximately fifteen major single-author review papers that have been extensively cited (between 100-500 times).
As the founder and convener of the International MAOI Expert Group and the Chairman of its presiding council, Dr. Gillman has played a pivotal role in advancing the understanding and clinical application of MAOIs in psychiatry. He is also an invited expert participant in the Malignant Hyperthermia Association of the US (MHAUS) expert group.
With his vast expertise and groundbreaking research contributions, Dr. Gillman is highly regarded as a thought leader and innovator in the field of psychiatry. His insights and perspectives are sure to enrich any discussion and deepen our understanding of the clinical application of MAOIs and TCAs in modern psychiatry practice.
Dr. Sanil Rege Course Host | MBBS, MRCPsych, FRANZCP
Dr Sanil Rege is a consultant psychiatrist and academic with dual qualifications from the UK and Australia. He is a Fellow of the Royal Australian and New Zealand College of Psychiatrists and a Member of the Royal College of Psychiatrists (UK).
Dr Rege has 20 years of clinical experience and 13 years of private practice experience, treating disorders across the full spectrum. He currently works in the community, across in-patient, consultation-liaison and addiction psychiatry spaces.
